focus -WSS

focus

author：knowledge 2025-08-23 08:53:03 - browse：2758

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： What to expect at HLTH 2023, the health care industry conference

entertainment

WSS

3 questions for the future of Biden's cancer moonshot

Most antidepressants don't work on kids, teens, study finds

Brain MRIs reveal impact of 'toxic stress' on Black children

The creative science of coining drug names

Chemotherapy drug shortage eases slightly but still widespread

Most antidepressants don't work on kids, teens, study finds

focus

focus

explore

Wildfire smoke exposes gaps in outdoor worker protections

Is it ever OK for doctors to lie to their patients?

Guidelines to prevent youth baseball injuries need more muscle

Most antidepressants don't work on kids, teens, study finds

Virginia high school admissions case could be legal follow

Was Amgen transparent enough on FDA's concern on cancer drug?

Anesthesiologist group: stop taking Ozempic before surgery

VC firm General Catalyst wants to buy a health system

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Crowdfunding for medical bills sidesteps core problem, author says

hotspot

Most antidepressants don't work on kids, teens, study finds

Empower primary care with adequate payments and technology

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Analysis of telehealth claims data suggest service duplication

Welsh Carson private equity firm escapes from FTC antitrust case

HHS's proposed rule does nothing to address the climate crisis

entertainment

hotspot

entertainment

focus